Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Clinical trial NCT05509595 · COMPLETED
Trial details
- NCT number
- NCT05509595
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2024-11-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.